A Phase II Study of Chiauranib in Combine With Capecitabine in TNBC
Clinical trial NCT05336721 · TERMINATED
Trial details
- NCT number
- NCT05336721
- Sponsor
- Chipscreen Biosciences, Ltd.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-05
- Primary completion
- 2024-10-31
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.